Minerva Neurosciences (NASDAQ:NERV) Stock Crosses Above 50 Day Moving Average – Here’s What Happened

Minerva Neurosciences, Inc. (NASDAQ:NERV)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.21 and traded as high as $2.69. Minerva Neurosciences shares last traded at $2.68, with a volume of 242,714 shares.

Wall Street Analyst Weigh In

NERV has been the subject of several recent research reports. StockNews.com began coverage on shares of Minerva Neurosciences in a report on Wednesday. They set a “sell” rating for the company. HC Wainwright reiterated a “neutral” rating and set a $5.00 price objective on shares of Minerva Neurosciences in a research note on Wednesday, November 6th.

Minerva Neurosciences Stock Performance

The business’s 50 day simple moving average is $2.21 and its two-hundred day simple moving average is $2.54.

Minerva Neurosciences Company Profile

Minerva Neurosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders.